Latest News and Press Releases
Want to stay updated on the latest news?
-
Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing FDA accepted NDA under Priority Review with a target...
-
Sparklight Strengthens Local Communities through More than $125,000 in Charitable Giving Fund Grants
Sparklight's Charitable Giving Fund awards over $125,000 to 28 nonprofits supporting digital literacy, food security and community programs.
-
CALGARY, Alberta, June 22, 2026 (GLOBE NEWSWIRE) -- Atlas Energy Corp. (“Atlas” or the “Company”) (TSXV: ATLE), a TSXV Sandbox issuer, is pleased to announce that Patrick Drouin and Dion Degrand...
-
HRCI, the career partner for the human resources profession, has been awarded a Top Workplaces 2026 honor by WTOP News for the third consecutive year.
-
D-Cycloserine (DCS) has been reported to augment the effect of Transcranial Magnetic Stimulation (TMS) in remission from depression and suicidality in several published clinical studies.NRx...
-
11 of 14 patients dosed had complete donor chimerism within ~three weeks of receiving first infusion of TSC-101; an additional two had improving chimerism following TSC-101 TSC-101 continues to be...
-
Lowell, Mich., June 22, 2026 (GLOBE NEWSWIRE) -- Navico Group, a division of Brunswick Corporation (NYSE: BC), today announced operational updates at its Lowell, Michigan facility. The changes are...
-
TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- McFarlane Lake Mining Limited (“McFarlane” or the “Company”) (CSE: MLM, OTC: MLMLF, FRA: W2Z) is pleased to announce further results from its diamond...
-
ZUG, Switzerland, June 22, 2026 (GLOBE NEWSWIRE) -- Lithium Argentina AG (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) is pleased to announce the results from its annual general...
-
Phase 1b clinical trial of SYX-5219 in adults with moderate to severe atopic dermatitis completes enrollment ahead of scheduleRapid progress in the United States and Europe reflects strong...